A dominant negative form of Egfr, with a stop codon introduced 20 amino acids C-terminal to the transmembrane domain, is expressed under the control of UASt regulatory sequences.
A dominant negative form of Egfr, with a stop codon introduced 20 amino acids C-terminal to the transmembrane domain, is expressed under the control of UASt regulatory sequences.